GOSS Gossamer Bio Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: GOSS

Price (delayed)

$8.53

Market cap

$647.51M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.46

Enterprise value

$388.23M

Highlights
The quick ratio is up by 26% year-on-year and by 16% since the previous quarter
GOSS's EPS is down by 4.5% year-on-year but it is up by 2.5% since the previous quarter
Gossamer Bio's net income has decreased by 22% YoY
GOSS's equity is down by 15% QoQ and by 11% YoY
Sector: Healthcare
Industry: Biotechnology
Website: https://www.gossamerbio.com/
Peers: OTIC ORIC

Key stats

What are the main financial stats of GOSS
Market
Shares outstanding
75.91M
Market cap
$647.51M
Enterprise value
$388.23M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.37
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$229.48M
EBITDA
-$224.83M
Free cash flow
-$184.75M
Per share
EPS
-$3.46
Free cash flow per share
-$2.49
Book value per share
$3.6
Revenue per share
$0
TBVPS
$6.51
Balance sheet
Total assets
$482.47M
Total liabilities
$210.39M
Debt
$180.94M
Equity
$272.08M
Working capital
$436.4M
Liquidity
Debt to equity
0.67
Current ratio
15.82
Quick ratio
15.41
Net debt/EBITDA
1.15
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-44.3%
Return on equity
-71.3%
Return on invested capital
-97.1%
Return on capital employed
-50.7%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

GOSS stock price

How has the Gossamer Bio stock price performed over time
Intraday
-1.95%
1 week
-3.51%
1 month
-5.12%
1 year
-32.09%
YTD
-11.79%
QTD
-7.78%

Financial performance

How have Gossamer Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$232.2M
Net income
-$246.93M
Gross margin
N/A
Net margin
N/A
Gossamer Bio's net income has decreased by 22% YoY
Gossamer Bio's operating income has decreased by 12% YoY

Growth

What is Gossamer Bio's growth rate over time

Valuation

What is Gossamer Bio stock price valuation
P/E
N/A
P/B
2.37
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
GOSS's EPS is down by 4.5% year-on-year but it is up by 2.5% since the previous quarter
GOSS's equity is down by 15% QoQ and by 11% YoY

Efficiency

How efficient is Gossamer Bio business performance
Gossamer Bio's ROIC has plunged by 55% YoY and by 7% from the previous quarter
The company's return on equity fell by 33% YoY and by 3.9% QoQ
GOSS's ROA is up by 3.5% since the previous quarter and by 2.6% year-on-year

Dividends

What is GOSS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for GOSS.

Financial health

How did Gossamer Bio financials performed over time
GOSS's total assets is 129% higher than its total liabilities
GOSS's total assets is up by 30% YoY but it is down by 11% QoQ
The current ratio has grown by 26% YoY and by 17% from the previous quarter
The debt is 33% smaller than the equity
The company's debt to equity rose by 20% QoQ
GOSS's equity is down by 15% QoQ and by 11% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.